1 |
Pfizer Inc. et al v. Aurobindo Pharma Limited |
1:23-cv-00923 |
D.Del. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
2 |
Pfizer Inc. et al v. Aurobindo Pharma Limited |
1:23-cv-00923 |
D.Del. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
3 |
Pfizer Inc. et al v. Aurobindo Pharma Limited |
1:23-cv-00923 |
D.Del. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
4 |
Pfizer Inc. et al v. Aurobindo Pharma Limited |
1:23-cv-00923 |
D.Del. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
5 |
Pfizer Inc. et al v. Aurobindo Pharma Limited |
1:23-cv-00923 |
D.Del. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
6 |
Vertex Pharmaceuticals Incorporated v. Aurobindo Pharma Limited et al |
1:23-cv-00582 |
D.Del. |
|
|
|
|
7 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
8 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
9 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
10 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
11 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
12 |
Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al |
1:23-cv-00039 |
D.Del. |
|
|
|
|
13 |
Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al |
1:23-cv-00039 |
D.Del. |
|
|
|
|
14 |
Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al |
1:23-cv-00039 |
D.Del. |
|
|
|
|
15 |
CHIESI USA INC. et al v. EUGIA PHARMA SPECIALITIES LIMITED (A.K.A. EUGIA PHARMA SPECIALTIES LIMITED) et al |
3:23-cv-00022 |
D.N.J. |
|
|
|
|
16 |
CHIESI USA INC. et al v. EUGIA PHARMA SPECIALITIES LIMITED (A.K.A. EUGIA PHARMA SPECIALTIES LIMITED) et al |
3:23-cv-00022 |
D.N.J. |
|
|
|
|
17 |
Alcon Inc. et al v. Aurobindo Pharma Ltd. et al |
1:22-cv-01391 |
D.Del. |
|
|
|
|
18 |
Alcon Inc. et al v. Aurobindo Pharma Ltd. et al |
1:22-cv-01391 |
D.Del. |
|
|
|
|
19 |
Merck KGaA et al v. Hopewell Pharma Ventures, Inc., et al. |
1:22-cv-01365 |
D.Del. |
|
|
|
|
20 |
Merck KGaA et al v. Hopewell Pharma Ventures, Inc., et al. |
1:22-cv-01365 |
D.Del. |
|
|
|
|
21 |
Merck KGaA et al v. Hopewell Pharma Ventures, Inc., et al. |
1:22-cv-01365 |
D.Del. |
|
|
|
|
22 |
Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al |
1:22-cv-01270 |
D.Del. |
|
|
|
|
23 |
Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al |
1:22-cv-01270 |
D.Del. |
|
|
|
|
24 |
Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al |
1:22-cv-01270 |
D.Del. |
|
|
|
|
25 |
Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al |
1:22-cv-00971 |
D.Del. |
|
|
|
|
26 |
Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al |
1:22-cv-00971 |
D.Del. |
|
|
|
|
27 |
BIOMARIN PHARMACEUTICAL INC. et al v. AUROBINDO PHARMACEUTICALS LTD. et al |
3:22-cv-02345 |
D.N.J. |
|
|
|
|
28 |
BIOMARIN PHARMACEUTICAL INC. et al v. AUROBINDO PHARMACEUTICALS LTD. et al |
3:22-cv-02345 |
D.N.J. |
|
|
|
|
29 |
Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al |
1:20-cv-00632 |
D.Del. |
|
|
|
|
30 |
Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al |
1:20-cv-00632 |
D.Del. |
|
|
|
|
31 |
Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al |
1:20-cv-00632 |
D.Del. |
|
|
|
|
32 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
33 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
34 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
35 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
36 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
37 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
38 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
39 |
Anacor Pharmaceuticals, Inc. v. Ascent Pharmaceuticals, Inc. et al |
1:18-cv-01673 |
D.Del. |
|
|
|
|
40 |
FOREST LABORATORIES, LLC et al v. AUROBINDO PHARMA USA, INC. et al |
2:17-cv-11679 |
D.N.J. |
|
|
|
|
41 |
FOREST LABORATORIES, LLC et al v. AUROBINDO PHARMA USA, INC. et al |
2:17-cv-11679 |
D.N.J. |
|
|
|
|
42 |
FOREST LABORATORIES, LLC et al v. AUROBINDO PHARMA USA, INC. et al |
2:17-cv-11679 |
D.N.J. |
|
|
|
|
43 |
FOREST LABORATORIES, LLC et al v. AUROBINDO PHARMA USA, INC. et al |
2:17-cv-11679 |
D.N.J. |
|
|
|
|
44 |
CELGENE CORPORATION v. HETERO LABS LIMITED et al |
2:17-cv-03387 |
D.N.J. |
|
|
|
|
45 |
Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al |
1:17-cv-00483 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
46 |
Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al |
1:17-cv-00483 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
47 |
Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al |
1:17-cv-00483 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
48 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
49 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
50 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|